EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis

Abstract Background Hepatitis B virus (HBV)-encoded X antigen, HBx, assists in the development of hepatocellular carcinoma (HCC) through complex mechanisms. Our results provide new insights into the EZH2 epigenetic repression of let-7c that promotes HCC migration induced by HBx. Thus, let-7c and HMG...

Full description

Bibliographic Details
Main Authors: Chen-Shiou Wu, Yi-Chung Chien, Chia‐Jui Yen, Jia-Yan Wu, Li-Yuan Bai, Yung-Luen Yu
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-023-03002-9
_version_ 1797451441678319616
author Chen-Shiou Wu
Yi-Chung Chien
Chia‐Jui Yen
Jia-Yan Wu
Li-Yuan Bai
Yung-Luen Yu
author_facet Chen-Shiou Wu
Yi-Chung Chien
Chia‐Jui Yen
Jia-Yan Wu
Li-Yuan Bai
Yung-Luen Yu
author_sort Chen-Shiou Wu
collection DOAJ
description Abstract Background Hepatitis B virus (HBV)-encoded X antigen, HBx, assists in the development of hepatocellular carcinoma (HCC) through complex mechanisms. Our results provide new insights into the EZH2 epigenetic repression of let-7c that promotes HCC migration induced by HBx. Thus, let-7c and HMGA2 represent key diagnostic markers and potential therapeutic targets for the treatment of HBV-related HCC. Results We investigated the epigenetic regulation of let-7c, an important representative miRNA in liver tumor metastasis, in human HCC cells to verify the effect of HBx. Based on quantitative PCR (qPCR) of mRNA isolated from tumor and adjacent non-tumor liver tissues of 24 patients with HBV-related HCC, EZH2 expression was significantly overexpressed in most HCC tissues (87.5%). We executed a miRNA microarray analysis in paired HBV-related HCC tumor and adjacent non-tumorous liver tissue from six of these patients and identified let-7c, miR-199a-3p, and miR-99a as being downregulated in the tumor tissue. Real-time PCR analysis verified significant downregulation of let-7c and miR-99a in both HepG2X and Hep3BX cells, which stably overexpress HBx, relative to parental cells. HBX enhanced EZH2 expression and attenuated let-7c expression to induce HMGA2 expression in the HCC cells. Knockdown of HMGA2 significantly downregulated the metastatic potential of HCC cells induced by HBx. Conclusions The deregulation of let-7c expression by HBx may indicate a potential novel pathway through deregulating cell metastasis and imply that HMGA2 might be used as a new prognostic marker and/or as an effective therapeutic target for HCC.
first_indexed 2024-03-09T14:54:42Z
format Article
id doaj.art-f04c244483694cb8ac2dbbc76756ab8c
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-03-09T14:54:42Z
publishDate 2023-09-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-f04c244483694cb8ac2dbbc76756ab8c2023-11-26T14:18:12ZengBMCCancer Cell International1475-28672023-09-0123111110.1186/s12935-023-03002-9EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasisChen-Shiou Wu0Yi-Chung Chien1Chia‐Jui Yen2Jia-Yan Wu3Li-Yuan Bai4Yung-Luen Yu5Institute of Translational Medicine and New Drug DevelopmentInstitute of Translational Medicine and New Drug DevelopmentDivision of Hematology and Oncology, Department of Internal Medicine, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung UniversityInstitute of Translational Medicine and New Drug DevelopmentDivision of Hematology and Oncology, China Medical University HospitalInstitute of Translational Medicine and New Drug DevelopmentAbstract Background Hepatitis B virus (HBV)-encoded X antigen, HBx, assists in the development of hepatocellular carcinoma (HCC) through complex mechanisms. Our results provide new insights into the EZH2 epigenetic repression of let-7c that promotes HCC migration induced by HBx. Thus, let-7c and HMGA2 represent key diagnostic markers and potential therapeutic targets for the treatment of HBV-related HCC. Results We investigated the epigenetic regulation of let-7c, an important representative miRNA in liver tumor metastasis, in human HCC cells to verify the effect of HBx. Based on quantitative PCR (qPCR) of mRNA isolated from tumor and adjacent non-tumor liver tissues of 24 patients with HBV-related HCC, EZH2 expression was significantly overexpressed in most HCC tissues (87.5%). We executed a miRNA microarray analysis in paired HBV-related HCC tumor and adjacent non-tumorous liver tissue from six of these patients and identified let-7c, miR-199a-3p, and miR-99a as being downregulated in the tumor tissue. Real-time PCR analysis verified significant downregulation of let-7c and miR-99a in both HepG2X and Hep3BX cells, which stably overexpress HBx, relative to parental cells. HBX enhanced EZH2 expression and attenuated let-7c expression to induce HMGA2 expression in the HCC cells. Knockdown of HMGA2 significantly downregulated the metastatic potential of HCC cells induced by HBx. Conclusions The deregulation of let-7c expression by HBx may indicate a potential novel pathway through deregulating cell metastasis and imply that HMGA2 might be used as a new prognostic marker and/or as an effective therapeutic target for HCC.https://doi.org/10.1186/s12935-023-03002-9EZH2let-7cmiR-99aHepatitis B Virus X AntigenHepatocellular Carcinoma
spellingShingle Chen-Shiou Wu
Yi-Chung Chien
Chia‐Jui Yen
Jia-Yan Wu
Li-Yuan Bai
Yung-Luen Yu
EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis
Cancer Cell International
EZH2
let-7c
miR-99a
Hepatitis B Virus X Antigen
Hepatocellular Carcinoma
title EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis
title_full EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis
title_fullStr EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis
title_full_unstemmed EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis
title_short EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis
title_sort ezh2 mediated epigenetic silencing of tumor suppressive let 7c mir 99a cluster by hepatitis b virus x antigen enhances hepatocellular carcinoma progression and metastasis
topic EZH2
let-7c
miR-99a
Hepatitis B Virus X Antigen
Hepatocellular Carcinoma
url https://doi.org/10.1186/s12935-023-03002-9
work_keys_str_mv AT chenshiouwu ezh2mediatedepigeneticsilencingoftumorsuppressivelet7cmir99aclusterbyhepatitisbvirusxantigenenhanceshepatocellularcarcinomaprogressionandmetastasis
AT yichungchien ezh2mediatedepigeneticsilencingoftumorsuppressivelet7cmir99aclusterbyhepatitisbvirusxantigenenhanceshepatocellularcarcinomaprogressionandmetastasis
AT chiajuiyen ezh2mediatedepigeneticsilencingoftumorsuppressivelet7cmir99aclusterbyhepatitisbvirusxantigenenhanceshepatocellularcarcinomaprogressionandmetastasis
AT jiayanwu ezh2mediatedepigeneticsilencingoftumorsuppressivelet7cmir99aclusterbyhepatitisbvirusxantigenenhanceshepatocellularcarcinomaprogressionandmetastasis
AT liyuanbai ezh2mediatedepigeneticsilencingoftumorsuppressivelet7cmir99aclusterbyhepatitisbvirusxantigenenhanceshepatocellularcarcinomaprogressionandmetastasis
AT yungluenyu ezh2mediatedepigeneticsilencingoftumorsuppressivelet7cmir99aclusterbyhepatitisbvirusxantigenenhanceshepatocellularcarcinomaprogressionandmetastasis